Jian Campian

7.3k total citations
117 papers, 2.8k citations indexed

About

Jian Campian is a scholar working on Genetics, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jian Campian has authored 117 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Genetics, 49 papers in Oncology and 42 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jian Campian's work include Glioma Diagnosis and Treatment (76 papers), Brain Metastases and Treatment (30 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Jian Campian is often cited by papers focused on Glioma Diagnosis and Treatment (76 papers), Brain Metastases and Treatment (30 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Jian Campian collaborates with scholars based in United States, Canada and China. Jian Campian's co-authors include Stuart A. Grossman, Xiaobu Ye, Jiayi Huang, Malcolm V. Brock, Albert H. Kim, John W. Eaton, Xueshan Gao, Mingwei Qian, Joseph M. Herman and Susannah G. Ellsworth and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jian Campian

108 papers receiving 2.8k citations

Peers

Jian Campian
Jiayi Huang United States
Helen Wheeler Australia
Kevin A. Walter United States
Gerda Ricken Austria
Oliver Bähr Germany
Oliver Heese Germany
Tony J. C. Wang United States
Jiayi Huang United States
Jian Campian
Citations per year, relative to Jian Campian Jian Campian (= 1×) peers Jiayi Huang

Countries citing papers authored by Jian Campian

Since Specialization
Citations

This map shows the geographic impact of Jian Campian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Campian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Campian more than expected).

Fields of papers citing papers by Jian Campian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Campian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Campian. The network helps show where Jian Campian may publish in the future.

Co-authorship network of co-authors of Jian Campian

This figure shows the co-authorship network connecting the top 25 collaborators of Jian Campian. A scholar is included among the top collaborators of Jian Campian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian Campian. Jian Campian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Campian, Jian, Omar H. Butt, Marc D. Ruben, et al.. (2025). Tracking Daily Variations in Rest-Wake to Guide Personalized Timing of Temozolomide for High-Grade Glioma Patients. Journal of Biological Rhythms. 40(4). 320–329. 1 indexed citations
2.
Lehrer, Eric J., et al.. (2024). Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma. International Journal of Molecular Sciences. 25(19). 10570–10570. 7 indexed citations
3.
Webb, Mason, et al.. (2024). A case series of osseous metastases in patients with glioblastoma. Medicine. 103(27). e38794–e38794.
4.
Campian, Jian, et al.. (2024). Upper Tract Urothelial Carcinoma Complicated by Skeletal Muscle Metastases. Journal of Medical Cases. 15(2-3). 60–65.
5.
Huang, Jiayi, Jian Campian, T.A. DeWees, et al.. (2024). A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 120(3). 738–749. 11 indexed citations
6.
Webb, Mason, et al.. (2023). Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions. SHILAP Revista de lepidopterología. 7(2). 97–110. 14 indexed citations
7.
Webb, Mason, Bryan J. Neth, Jamie J. Van Gompel, et al.. (2023). Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients. Neuro-Oncology Advances. 5(1). vdad123–vdad123. 4 indexed citations
8.
Plotkin, Scott R., Jeffrey C. Allen, Girish Dhall, et al.. (2023). Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro-Oncology. 25(8). 1498–1506. 12 indexed citations
9.
Galanis, Evanthia, S. Keith Anderson, Erin Twohy, et al.. (2022). Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance). Neuro-Oncology Advances. 4(1). vdac041–vdac041. 6 indexed citations
10.
Luo, Jingqin, Emily A. Slat, Katherine N. Weilbaecher, et al.. (2022). A randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma. Neuro-Oncology Practice. 9(3). 193–200. 21 indexed citations
11.
Butt, Omar H., Alice Y. Zhou, Jiayi Huang, et al.. (2021). A phase II study of laser interstitial thermal therapy combined with doxorubicin in patients with recurrent glioblastoma. Neuro-Oncology Advances. 3(1). vdab164–vdab164. 38 indexed citations
12.
Ma, Si‐Rui, Soumon Rudra, Jian Campian, et al.. (2021). Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma. Neuro-Oncology Advances. 3(1). vdab081–vdab081. 1 indexed citations
13.
Ye, Zezhong, Richard L. Price, Qingsong Yang, et al.. (2020). Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology. Clinical Cancer Research. 26(20). 5388–5399. 22 indexed citations
14.
Plotkin, Scott R., Dan G. Duda, Alona Muzikansky, et al.. (2019). Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. Journal of Clinical Oncology. 37(35). 3446–3454. 74 indexed citations
15.
Huang, Jiayi, Rekha Chaudhary, Adam L. Cohen, et al.. (2019). A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma. Journal of Neuro-Oncology. 142(3). 537–544. 82 indexed citations
16.
Huang, Jiayi, Jian Campian, Amit D. Gujar, et al.. (2018). Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma. Journal of Neuro-Oncology. 138(1). 105–111. 45 indexed citations
17.
Lin, Alexander J., Caressa Hui, Sonika Dahiya, et al.. (2018). Radiologic Response and Disease Control of Recurrent Intracranial Meningiomas Treated With Reirradiation. International Journal of Radiation Oncology*Biology*Physics. 102(1). 194–203. 14 indexed citations
18.
Acharya, Sahaja, Clifford G. Robinson, Jeff M. Michalski, et al.. (2018). Association of 1p/19q Codeletion and Radiation Necrosis in Adult Cranial Gliomas After Proton or Photon Therapy. International Journal of Radiation Oncology*Biology*Physics. 101(2). 334–343. 22 indexed citations
19.
Huang, Jiayi, Pamela Samson, Stephanie M. Perkins, et al.. (2016). Impact of concurrent chemotherapy with radiation therapy for elderly patients with newly diagnosed glioblastoma: a review of the National Cancer Data Base. Journal of Neuro-Oncology. 131(3). 593–601. 20 indexed citations
20.
Huang, Jiayi, T.A. DeWees, Shahed N. Badiyan, et al.. (2015). Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma. International Journal of Radiation Oncology*Biology*Physics. 92(5). 1000–1007. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026